摘要:
Methods of treating and preventing conditions of a nasal or paranasal mucous membrane are described. The methods include administering a pharmaceutical composition including a nicotinic acetylcholine receptor (nAChR) agonist, such as (S)-(1-methyl-2-pyrrolidinyl)-pyridine, or a pharmaceutically acceptable salt, analog, precursor or derivative thereof. The methods can be used to treat a wide variety of conditions of the nasal or paranasal mucous membrane, such as nasal congestion and nose bleeds.
摘要:
An electrochemical process and system for producing glucose are described. The process and system allow for the production of glucose from carbon dioxide and water, requiring only melanin, or a precursor, derivative, analog, or variant of melanin, and electromagnetic energy, such as visible or invisible light energy.
摘要:
Methods of fertilizing soil, and of increasing a crop yield, plant growth, and rate of seed germination using melanin, or a melanin precursor, derivative, or analog are provided. The methods described herein require water, melanin, or a melanin precursor, derivative, or analog, and a source of electromagnetic energy, such as visible or invisible light energy, to catalyze the electrolysis of water. The electrolysis of water causes the release of diatomic hydrogen into the soil, resulting in fertilization of the soil. Also provided are fertilized soil compositions.
摘要:
Methods of treating renal failure are described. In particular, methods of treating renal failure by administration of pharmaceutical composition including a mixture of nicotine and salicylic acid are described.
摘要:
Methods of producing non-human animal models of corneal angiogenesis and corneal ectatic diseases, such as corneal keratoconus, by applying an aromatic compound to the eye of a non-human animal are described. Also described are non-human animal models of corneal angiogenesis and corneal ectatic diseases, and methods of using the non-human animal models to screen compounds that modulate corneal angiogenesis and corneal ectatic diseases.
摘要:
The present invention refers to a cement composition that contains dopamelanin, its precursors and/or its analogues as an additive in a maximum percentage of 30% of the cement. This additive substitutes water of the capillary nets. The mentioned cement mixture posses a water/cement relation of 0.2 to 0.4, optionally it can contain different sand and gravel proportions. This cement mixture generates strong chemical bonds, and increased scouring resistance, of at least 28% and a higher elastic resistance of the concrete, of at least 50%. Its cracking in early stages is very low or practically null. The present request also refers to the use of dopamelanin and/or its precursors and/or its analogues as an additive of the cement mixture that substitutes the capillary water proportion in the cementant mixture. Just as well the use of dopamelanin and/or its precursors and/or its analogues, in an aqueous solution, in less that 3%, as a concrete setting and curing agent, thus it significantly increases the ductility and scouring resistance of the cement mixture. This is, the novelty cement mixture improves the physicochemical and bacteriological properties of the usual concrete, being of special interest the notable increment related with compression resistance and ductility or relative displacements, suffering less damage in comparison with the mixture containing water. In a meaningful way, it also increases since early stages, the volumetric stability of the concrete, thus it intensifies its scouring resistance, which is inclusive transmitter to the metallic elements immersed in its interior, since certainly it significantly protects them from deterioration.
摘要:
The invention essentially consists in the use of melanins, melanin precursors or melanin derivatives, melanin variants, melanin analogues, natural or synthetic, pure or mixed with organic or inorganic compounds, metals, ions, drugs; as water electrolyzing material, using as sole or main source of energy, natural or synthetic light, coherent or not; in the systems of hydrogen production from water, known as photoelectrochemical systems. These systems integrate as semiconductor material and a water electrolyzer inside a monolithic design, to produce hydrogen directly from water, using light (between 200 to 900 nm) as the main or sole source of energy. At least to basic criteria had to be met: one was that the system or light absorbing compound should generate enough energy to start, lead and complete the photoelectrolysis reaction, being economical, stable and lasting in a water system, requirements met by melanins, representing thus an important and critical advance to solve the central problem of photoelectrochemical designs. The procedure can be applied to generate hydrogen, oxygen and high energy electrons, or the opposite sense, i.e., synthesizing water from the union of hydrogen and oxygen, generating electricity; it can be coupled to other processes, generating a multiplication effect; it can also be used for reduction of carbon dioxide, nitrates and sulphates or others.
摘要:
A solid-state battery is provided. The battery includes a melanin structure formed of at least one melanin material embedded in an inert material, and first and second metal bands which serve as first and second electrodes, respectively. The melanin material is selected from the group consisting of melanin, melanin precursors, melanin derivatives, melanin analogs and melanin variants. The solid-state battery does not need to be recharged or reloaded.
摘要:
A textile has an active outside surface and an active inside surface including optical fibers covering at least partially the active outside surface, wherein the active outside surface captures light, which is transmitted by the optical fibers to the active inside surface.
摘要:
Methods of producing non-human animal models of corneal angiogenesis and corneal ectatic diseases, such as corneal keratoconus, by applying an aromatic compound to the eye of a non-human animal are described. Also described are non-human animal models of corneal angiogenesis and corneal ectatic diseases, and methods of using the non-human animal models to screen compounds that modulate corneal angiogenesis and corneal ectatic diseases.